Esketamine Nasal Spray Demonstrates Rapid Improvements in Treatment-Resistant Depression - MD Magazine

MD MagazineEsketamine Nasal Spray Demonstrates Rapid Improvements in Treatment-Resistant DepressionMD MagazineHusseini Manji, MD. Janssen Pharmaceuticals announced results from 2 phase 3 clinical studies of the investigational compound esketamine nasal spray in patients with treatment-resistant major depressive disorder (MDD.) The studies, presented at the ...Esketamine Nasal Spray Posts Positive Results in Two Phase 3 TrialsPsych Congress NetworkNew Phase 3 Data Show Esketamine Nasal Spray Demonstrated Rapid Improvements in Depressive Symptoms in ...Benzingaall 8 news articles »